Comparative pharmacokinetics of vindesine, vincristine and vinblastine in patients with cancer

Cancer Treatment Reviews

Volumn 7, Issue SUPPL. 1, 1980, Pages 17-24

  Nelson, R L ^a   Dyke, R W ^a   Root, M A ^a  

^a WISHARD MEMORIAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VINBLASTINE; VINCRISTINE; VINDESINE;

CANCER CHEMOTHERAPY; COMPUTER ANALYSIS; DRUG BLOOD LEVEL; DRUG COMPARISON; DRUG URINE LEVEL; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; METASTASIS; PHARMACOKINETICS; THERAPY;

ANTINEOPLASTIC AGENTS; COMPARATIVE STUDY; HUMAN; KINETICS; NEOPLASMS; VINBLASTINE; VINCRISTINE; VINDESINE;

EID: 0019124123     PISSN: 03057372     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0305-7372(80)80003-X     Document Type: Article

References (17)

1. 3H]-vincristine in man
2. 3H]-vindesine in rats
3. Vindesine. A short review of preclinical and first clinical data
4. Vindesine. A review of phase II trials
5. MLAB: A civilized curve fitting system
6. An initial report of a phase III trial comparing vindesine and vincristine for acute lymphocytic leukemia of childhood
7. Phase II clinical trial with vindesine for remission induction in acute leukemia, blastic crisis of chronic myeloid leukemia, lymphosarcoma, and Hodgkin's disease: absence of cross-resistance with vincristine
8. Phase I–II Clinical investigation of vindesine (desacetyl vinblastine amide sulfate)
9. Vindesine. A clinical trial with special reference to neurological side effects
10. Vindesine as a single agent in the treatment of advanced malignant melanoma
11. Evaluation of vindesine in treatment of recurrent malignant lymphomas
12. Vindesine—a phase II study in the treatment of breast carcinoma, malignant melanoma, and other tumors
13. Vindesine in the treatment of breast cancer
14. Experimental antitumor activity of vinblastine amides